Yoshitaka Nagai

Title: Innovations of Yoshitaka Nagai

Introduction

Yoshitaka Nagai is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides.

Latest Patents

Nagai holds a patent for an antisense oligonucleotide that controls the expression amount of TDP-43. This invention provides a suppression type antisense oligonucleotide targeting TDP-43 mRNA, which contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in any of SEQ ID NOs: 2-4. Additionally, it includes a promotion type antisense oligonucleotide targeting TDP-43 mRNA, containing a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in SEQ ID NO: 5.

Career Highlights

Throughout his career, Yoshitaka Nagai has worked with prestigious institutions, including Osaka University and Knc Laboratories Co., Ltd. His work has focused on advancing the understanding and application of antisense technology in medical research.

Collaborations

Nagai has collaborated with notable colleagues such as Kazuhiro Maeta and Toshihide Takeuchi. Their combined expertise has contributed to the success of various projects in the field of biotechnology.

Conclusion

Yoshitaka Nagai's innovative work in antisense oligonucleotides highlights his significant role in advancing biotechnology. His contributions continue to impact the scientific community and pave the way for future research.